BSD Medical Corp. will feature its BSD-2000/3D/MR cancer treatment system at ASTRO 2008, which has been adapted to treat children with cancer.
To accommodate the treatment of children, BSD has developed treatment applications specifically sized for small and medium-sized children and that are capable of delivering pediatric cancer therapy during simultaneous magnetic resonance imaging (MRI) during the treatment process.
The BSD-2000/3D/MR was developed by BSD and Siemens Medical Solutions. Initial targets for treatment of children’s cancers include germ cell tumors and soft tissue sarcomas.
BSD said it's currently shipping a Sigma 40/MR pediatric applicator to Erlangen University Medical School in Germany, an applicator that will be an upgrade to the BSD-2000/3D/MR system.
October 30, 2026 
